Table 3.
Summary of various prognosticators and development of treatment failure (BNI IV-V)
| Variable | Good outcome | Treatment failure | P-value |
|---|---|---|---|
| No of patients | 18 (72%) | 7 (28%) | 0.05 |
| Gender | |||
| Male | 10 | 3 | 0.51 |
| Female | 8 | 4 | |
| Age | |||
| ≥70 years | 7 | 3 | 0.81 |
| <70 years | 11 | 4 | |
| Diabetes | 0.05 | ||
| Yes | 2 | 3 | |
| No | 16 | 4 | |
| Multiple Sclerosis | 0.88 | ||
| Yes | 3 | 1 | |
| No | 14 | 6 | |
| Side of Pain | |||
| Right | 9 | 5 | 0.38 |
| Left | 9 | 2 | |
| Duration of | |||
| Symptoms | |||
| >8 years | 12 | 4 | 0.74 |
| <8 years | 6 | 3 | |
| Dose | |||
| 60 Gy | 14 | 5 | 0.68 |
| >60 Gy | 4 | 2 | |
| New Bothersome | 0.20 | ||
| Facial Numbness | 4 | 7 | |
| Yes | 14 | 0 | |
| No | |||
| Post-treatment BNI | |||
| Facial Numbness | |||
| I-II | 10 | 7 | 0.04 |
| III-IV | 8 | 0 | |
| Prior Surgery | |||
| Yes | 13 | 4 | 0.40 |
| No | 5 | 3 |